Literature DB >> 23948581

Through thick and thin: a circulating growth factor inhibits age-related cardiac hypertrophy.

Alexandra C McPherron1.   

Abstract

In an intriguing new study, Loffredo et al report that joining the circulation of old mice with that of young mice reduces age-related cardiac hypertrophy. They also found that the growth factor growth/differentiation factor 11 is a circulating negative regulator of cardiac hypertrophy which suggests that raising growth/differentiation factor 11 levels may be useful to treat cardiac hypertrophy associated with aging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23948581      PMCID: PMC3800187          DOI: 10.1161/CIRCRESAHA.113.302239

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  48 in total

1.  Assigning the positional identity of spinal motor neurons: rostrocaudal patterning of Hox-c expression by FGFs, Gdf11, and retinoids.

Authors:  J P Liu; E Laufer; T M Jessell
Journal:  Neuron       Date:  2001-12-20       Impact factor: 17.173

Review 2.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

3.  Parabiosis in physiological studies.

Authors:  J C FINERTY
Journal:  Physiol Rev       Date:  1952-07       Impact factor: 37.312

4.  Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb.

Authors:  L W Gamer; K A Cox; C Small; V Rosen
Journal:  Dev Biol       Date:  2001-01-15       Impact factor: 3.582

5.  GDF11 controls the timing of progenitor cell competence in developing retina.

Authors:  Joon Kim; Hsiao-Huei Wu; Arthur D Lander; Karen M Lyons; Martin M Matzuk; Anne L Calof
Journal:  Science       Date:  2005-06-24       Impact factor: 47.728

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

8.  Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

9.  Blockade of the activin receptor IIb activates functional brown adipogenesis and thermogenesis by inducing mitochondrial oxidative metabolism.

Authors:  Brigitte Fournier; Ben Murray; Sabine Gutzwiller; Stefan Marcaletti; David Marcellin; Sebastian Bergling; Sophie Brachat; Elke Persohn; Eliane Pierrel; Florian Bombard; Shinji Hatakeyama; Anne-Ulrike Trendelenburg; Frederic Morvan; Brian Richardson; David J Glass; Estelle Lach-Trifilieff; Jerome N Feige
Journal:  Mol Cell Biol       Date:  2012-05-14       Impact factor: 4.272

10.  The ageing systemic milieu negatively regulates neurogenesis and cognitive function.

Authors:  Saul A Villeda; Jian Luo; Kira I Mosher; Bende Zou; Markus Britschgi; Gregor Bieri; Trisha M Stan; Nina Fainberg; Zhaoqing Ding; Alexander Eggel; Kurt M Lucin; Eva Czirr; Jeong-Soo Park; Sebastien Couillard-Després; Ludwig Aigner; Ge Li; Elaine R Peskind; Jeffrey A Kaye; Joseph F Quinn; Douglas R Galasko; Xinmin S Xie; Thomas A Rando; Tony Wyss-Coray
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

View more
  3 in total

Review 1.  Systemic milieu and age-related deterioration.

Authors:  Hongxia Zhang; Ryan Cherian; Kunlin Jin
Journal:  Geroscience       Date:  2019-05-31       Impact factor: 7.713

2.  MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR.

Authors:  Xuemei Sun; Chunlai Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 3.  New Treatment Strategies for Alcohol-Induced Heart Damage.

Authors:  Joaquim Fernández-Solà; Ana Planavila Porta
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.